+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Gastroesophageal Reflux Disease (GERD) - Pipeline Insight, 2025 - Product Thumbnail Image

Gastroesophageal Reflux Disease (GERD) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Gaucher's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Gaucher's Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Geographic Atrophy (GA)- Pipeline Insight, 2025 - Product Thumbnail Image

Geographic Atrophy (GA)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Glaucoma - Pipeline Insight, 2025 - Product Thumbnail Image

Glaucoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 170 Pages
  • Global
From
Hypogonadism- Pipeline Insight, 2025 - Product Thumbnail Image

Hypogonadism- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hypoparathyroidism - Pipeline Insight, 2025 - Product Thumbnail Image

Hypoparathyroidism - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
IgA Nephropathy- Pipeline Insight, 2025 - Product Thumbnail Image

IgA Nephropathy- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Immune Thrombocytopenia (ITP) - Pipeline Insight, 2025 - Product Thumbnail Image

Immune Thrombocytopenia (ITP) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Infantile Spasm - Pipeline Insight, 2025 - Product Thumbnail Image

Infantile Spasm - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Myocardial Infarction - Pipeline Insight, 2025 - Product Thumbnail Image

Myocardial Infarction - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
No Option Refractory Disabling Angina (NORDA) - Pipeline Insight, 2025 - Product Thumbnail Image

No Option Refractory Disabling Angina (NORDA) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Nocturnal Enuresis - Pipeline Insight, 2025 - Product Thumbnail Image

Nocturnal Enuresis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
Obsessive Compulsive Disorder- Pipeline Insight, 2025 - Product Thumbnail Image

Obsessive Compulsive Disorder- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Obstructive Sleep Apnea (OSA) - Pipeline Insight, 2025 - Product Thumbnail Image

Obstructive Sleep Apnea (OSA) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Ocular Hypertension - Pipeline Insight, 2025 - Product Thumbnail Image

Ocular Hypertension - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
Onychomycosis - Pipeline Insight, 2025 - Product Thumbnail Image

Onychomycosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Ophthalmoplegia - Pipeline Insight, 2025 - Product Thumbnail Image

Ophthalmoplegia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more